USA VC Funds

AAF Management Ltd., founded in 2016 and headquartered in Washington, D.C., is a prominent early-stage venture capital firm. The firm focuses on pre-seed, seed, and Series A stage technology companies in North America, with particular emphasis on sectors such as fintech, healthcare, consumer tech, enterprise software, and deep tech. AAF Management has an impressive portfolio of over 120 venture-backed companies. Notable investments include Robinhood, Didi, Savage X Fenty, StockX, Figure, Reddit, Current, Synthego, Jasper, and Drata. The firm has also celebrated significant exits, such as CrowdStrike (NASDAQ: CRWD), TruOptik (acquired by TransUnion), Even Financial (acquired by MoneyLion), Prodigy (acquired by Upstart), Portfolium (acquired by Instructure), and HeyDoctor (acquired by GoodRx). The firm is backed by over 95 limited partners, including family offices, royal families, C-level executives, and hedge fund managers from the US, Europe, and MENA regions. AAF Management prides itself on its strategic value-add, leveraging a vast network to support its portfolio companies and emerging managers globally.

AB Health Ventures, now operating under the name Cencora Ventures following AmerisourceBergen's rebranding to Cencora, is a $150 million venture capital fund. The fund focuses on early to mid-stage healthcare startups worldwide, prioritizing areas such as the future of pharmacy and distribution, clinical development, and commercialization of pharmaceuticals, healthcare provider solutions, and animal health. The fund leverages AmerisourceBergen's extensive expertise and global footprint to add value to its portfolio companies. It supports startups in rapidly prototyping solutions, conducting pilot tests, and accelerating commercialization. Notable recent investments include partnerships with TrakCel and Annexus Health, both leaders in their respective fields of cellular orchestration and healthcare technology. AB Health Ventures collaborates with Touchdown Ventures to manage its operations, ensuring that the fund's strategic and financial goals are met efficiently. The initiative aims to foster innovation in healthcare, driven by the belief that bold ideas and cutting-edge technologies can significantly improve patient outcomes and streamline healthcare delivery.

Abingworth, founded in 1973, is a transatlantic life sciences investment firm with a robust portfolio and a strategic focus on turning innovative science into transformative medical treatments. With offices in London, Boston, and San Francisco, Abingworth has invested in over 179 companies, resulting in 73 IPOs and 46 M&As. The firm operates across three main investment stages: seed and early-stage, development stage, and clinical co-development, and typically invests between $500,000 to $2 million in initial rounds, supporting portfolio companies through subsequent funding stages. Notable investments include Adaptate Biotherapeutics, Jasper, and Tizona Therapeutics. Abingworth's team, led by Managing Partners Tim Haines and Kurt von Emster, brings decades of experience in life sciences and venture capital. The firm is deeply embedded in key biotech hubs, facilitating productive interactions with entrepreneurs and access to top-tier scientific talent. The firm emphasizes long-term partnerships, providing not just capital but also strategic guidance in areas such as clinical development, regulatory approval, and commercialization. Abingworth's recent integration with Carlyle Group underscores its commitment to expanding its impact in the global healthcare investment ecosystem. Startups seeking investment from Abingworth should have groundbreaking science with the potential to materially improve patient outcomes. The firm values deep industry expertise, strong leadership, and a clear path to transformative impact.

Able Partners, founded in 2016 and based in New York City, is a venture capital firm that focuses on investing in early-stage companies aiming to improve daily lives through health and wellness. The firm is known for its support of passionate entrepreneurs and inspiring brands across various industries including consumer products, health tech, and wellness. Their diverse portfolio includes investments in companies such as Clare, a direct-to-consumer paint company; Alto Neuroscience, a company focused on precision psychiatry; Little Otter, a mental health service for children and families; and Kindred, a network for professional caregivers. Other notable investments are Beam Impact, Vivvi, and Capable Health. Able Partners has made over 60 investments and has achieved multiple successful exits. Key exits include Alto Neuroscience, Stretch*d, and Capable Health, showcasing their ability to support companies from early stages to successful outcomes. The firm is led by co-founders Lisa Blau and Amanda Eilian, who bring extensive experience in consumer-focused investments and entrepreneurship. Their investment strategy emphasizes not only providing capital but also leveraging their extensive networks and expertise to help portfolio companies achieve their full potential.

Abstract Ventures is a San Francisco-based VC firm founded in 2016, focusing on early-stage investments across biotech, consumer products, crypto, and enterprise frontier tech. The firm has gained a reputation for backing innovative and high-potential startups, with a portfolio that includes successes like Rippling and Material, the latter achieving unicorn status in 2022. Abstract Ventures primarily targets investments within the U.S., engaging in Seed and Series A rounds with typical check sizes ranging from $5 to $15 million. Their strategy blends flexibility with strategic partnerships, often co-investing with other VCs and leading rounds when they see transformative potential. Abstract is known for being founder-friendly, offering not just capital but also access to a wide network of industry experts, experienced entrepreneurs, and investors who can provide significant strategic value. In 2024, Abstract maintained a proactive stance, completing 16 new investments in companies such as Unify and Thirddimension.ai. The firm’s small yet powerful team is spearheaded by founder and General Partner Ramtin Naimi, who, along with four other partners, leverages years of investment experience and market insight from their base in San Francisco. Abstract Ventures advises founders to approach with a robust market strategy, proven product traction, and genuine storytelling. Rather than solely evaluating polished decks, the firm seeks authenticity and conviction in a startup’s vision. They primarily source deals through referrals and their network, emphasizing relationships and strategic alignment. With this approach, Abstract has carved out a distinctive presence in the early-stage VC landscape, empowering founders from idea to growth phase.

Abstraction Capital is an early-stage venture capital firm that focuses on supporting technical founders building tools for developers and technical users. With a sweet spot in pre-seed and seed rounds, Abstraction invests in companies that create products designed to free developers from non-core tasks, allowing them to focus on high-value activities. Notable investments include Buf, a schema design platform for APIs, and Freshpaint, a tool for seamlessly connecting websites to marketing stacks without code. They have also backed companies like Parabeac, which automates design-to-code workflows, and Octane, a platform for monetizing usage-based software, which was acquired by Stripe. Led by founder Taylor Clauson, Abstraction is rooted in the idea that the infrastructure behind software development holds immense opportunity. Clauson brings over a decade of experience, having previously worked at OpenAir Equity Partners, where he focused on IoT and data startups. Based in Kansas City, Abstraction maintains a developer-first ethos and prioritizes long-term partnerships, providing capital, mentorship, and technical insights to help startups scale from their earliest stages. Their portfolio reflects a deep commitment to enhancing developer productivity through innovative, technical solutions, emphasizing infrastructure, API management, and low-code platforms.

Accel is a renowned venture capital firm known for its strategic investments across various stages and sectors. Founded in 1983, Accel has played a pivotal role in the success of numerous high-profile companies. Some of its most notable investments include Facebook, Dropbox, Spotify, and Slack, showcasing its strength in identifying and backing transformative technology companies early on. The firm's investment strategy focuses on seed and Series A funding, ensuring deep engagement with startups from their inception. Accel emphasizes a collaborative approach, providing not just capital but also mentorship and strategic support to help entrepreneurs build market-defining businesses. This hands-on involvement has led Accel to lead investments in over 70% of its portfolio companies​. Accel operates globally, with key offices in Silicon Valley, London, and Bangalore, enabling it to tap into entrepreneurial talent worldwide. The firm has recently closed on several funds totaling $3.05 billion, aimed at supporting early-stage startups and growth rounds for more mature companies​​. In 2023, Accel made significant investments in companies like Blackpoint Cyber, Headway, and Cyera, reflecting its commitment to diverse sectors such as cybersecurity, mental health, and data protection​​. This broad sector focus, combined with a global investment perspective, positions Accel as a key player in the venture capital landscape, continuously driving innovation and supporting exceptional entrepreneurs around the world.

Access Venture Partners (AVP), based in Westminster, Colorado, has been a key player in the venture capital landscape since 1999. AVP focuses on early-stage investments, primarily in seed and Series A rounds, with particular interest in sectors such as cybersecurity, enterprise SaaS, and managed marketplaces. They look for startups with scalable business models and a clear path to significant market opportunities, often investing between $250k and $500k initially and maintaining reserves for follow-on support. The firm's portfolio boasts successful startups like Red Canary, LogRhythm, and Bonusly, reflecting their commitment to innovative technology companies in the Mountain West region and beyond. AVP values a hands-on approach, offering not just capital but also extensive operational support, leveraging over 100 combined years of expertise among its team members. Co-founded by Frank Mendicino III, who has a strong background in product development and sales, AVP's team includes Brian Wallace, an expert in venture capital finance and legal matters, and Eric Shu and Alex Houghtalin, who bring diverse experiences in strategy and entrepreneurship. Access Venture Partners prides itself on its founder-first philosophy, actively supporting the entrepreneurial community through mentorship, network introductions, and strategic guidance. This approach has enabled them to foster robust relationships with founders and help them navigate the critical early stages of growth

Accion Venture Lab is an early-stage venture fund focused on empowering inclusive fintech startups that serve underserved and low-income populations globally. Established as part of Accion, a nonprofit dedicated to financial inclusion, Venture Lab provides seed-first capital paired with extensive strategic and operational support to help startups scale and overcome early challenges. Their diverse portfolio features innovative companies like Apollo Agriculture, which offers tech-driven financing to smallholder farmers in Kenya and Zambia, and Bababos, an Indonesian platform that supports small-scale manufacturers with raw materials and financing solutions. With a geographic reach that spans Latin America, the Caribbean, sub-Saharan Africa, the Middle East, North Africa, Southeast Asia, and even parts of the U.S., Accion Venture Lab's commitment is global. The fund targets industries such as digital lending, insurtech, personal financial management, and MSME-focused solutions, identifying startups with a mission to address systemic barriers to financial access. Their strategy is unique in that they prefer being the first institutional investor, ensuring startups receive not just capital but high-touch mentorship and strategic guidance. In 2019, Accion Venture Lab boosted its support efforts by launching a $23 million fund aimed at deepening their investment into inclusive fintech. Their approach prioritizes not only financial backing but also leveraging their deep-rooted expertise in financial inclusion to provide hands-on operational assistance. The team is led by seasoned Managing Partners Amee Parbhoo and Rahil Rangwala, who bring years of experience in fintech, impact investing, and scaling social enterprises. Founders looking for support from Venture Lab should demonstrate impactful, scalable solutions with clear pathways to financial inclusion.

Accomplice Ventures, founded in 2015 and based in Boston, Massachusetts, is a prominent seed-led venture capital firm. The firm specializes in technology startups across various sectors including cybersecurity, eSports, data analytics, SMB software, emerging hardware platforms, and marketplaces. Notable investments by Accomplice include leading tech companies such as DraftKings, AngelList, Carbon Black, CoinList, Currencycloud, and FreshBooks. Their portfolio also features innovative firms like Hopper, Patreon, PillPack, SecurityScorecard, Veracode, and WHOOP. Accomplice has a significant track record of successful exits, with companies like Datadog, Snap, and DraftKings achieving substantial market presence and growth. Accomplice operates with a unique federated VC model, supporting initiatives such as the operator-angel movement through Spearhead and the blockchain sector via Accomplice Blockchain. They are also anchor LPs in numerous solo GP funds, reflecting their commitment to a diverse and dynamic investment strategy. The firm was initially part of Atlas Venture before the tech and life sciences groups split, with Accomplice focusing solely on tech investments. They have raised multiple funds, including $405 million for their final fund as of 2022, ensuring a robust financial backing for their portfolio companies. Accomplice's investment philosophy is centered on being high conviction, concentrated, and patient investors, dedicated to helping founders build successful, market-leading companies​.

ACME Capital is a prominent venture capital firm based in San Francisco, specializing in early-stage investments in disruptive technologies and innovative business models. Founded in 2013 by Hany Nada, Shervin Pishevar, and Scott Stanford, the firm focuses on sectors such as healthcare, financial services, and space exploration. Their notable investments include high-profile companies like Uber, Slack, and DraftKings, demonstrating a knack for identifying and nurturing industry leaders. ACME Capital's investment strategy is centered on supporting visionary founders who are tackling large-scale challenges with groundbreaking solutions. They emphasize platform shifts and technology breakthroughs that promise significant societal benefits. The firm typically leads funding rounds and provides not just capital, but also strategic guidance and operational support to help startups scale effectively. Geographically, ACME Capital has a strong focus on the United States, but their portfolio also includes companies with a global reach. Their commitment to diversity and inclusion is reflected in their investment choices, with a significant portion of their portfolio companies led by underrepresented founders. The team at ACME Capital includes experienced partners like Brian Yee and Alexander Fayette, who bring a wealth of expertise and a hands-on approach to their investment process. Entrepreneurs looking to engage with ACME Capital are encouraged to present bold, transformative ideas that have the potential to disrupt massive markets and drive significant impact.

ACME Capital, founded in 2018 and headquartered in San Francisco, is an early-stage venture capital firm specializing in transformative technologies and business model innovations. They invest in deep tech, hardware, disruptive consumer products, enterprise solutions, fintech, health, and web3 sectors. Notable portfolio companies include IonQ, Braintrust, Cue Health, Astra, Uhnder, and Forte, which exemplify ACME’s commitment to pioneering advancements and societal benefits. ACME's strategy emphasizes partnering with founders from ideation through to IPO, offering not just capital but also strategic support and valuable industry connections. They favor investments in companies demonstrating significant market traction and a clear path to scalability. Their recent Fund IV and adjacent Opportunity Fund raised over $300 million, underscoring their robust position in the venture capital landscape. ACME is also dedicated to diversity and inclusion, with a substantial portion of their investments and team members representing historically underrepresented groups. Key team members include Co-founders Hany Nada and Scott Stanford, who bring extensive experience in venture capital and entrepreneurship, enhancing ACME’s ability to guide startups toward successful exits.

Acorn Pacific Ventures, founded in 2015, is a venture capital firm based in San Mateo, California. The firm focuses on early and growth-stage technology companies, with a particular emphasis on cross-border investments between the U.S. and Asia. Their portfolio spans industries like e-commerce, AI, fintech, and healthcare, including notable investments in Reap, a Hong Kong-based fintech company, and PopChill, an e-commerce fashion platform. Acorn Pacific is known for its strategic expertise in cross-border expansion, helping startups navigate both Silicon Valley and Asia-Pacific markets. The firm targets companies that leverage proprietary technology and tackle complex challenges in Industry 4.0 and global supply chain transformation. Their typical investment range varies, but they are active in funding rounds from seed to Series B. Led by Chih-Kai Cheng and a team of experienced partners, Acorn Pacific provides not only capital but also operational support to help companies scale. Their portfolio includes ventures like Nuohui Health, Avatar Medical, and Proglix, demonstrating their strong presence across various tech-driven sectors​.

Acre Venture Partners, founded in 2016 and based in Santa Monica, California, is a venture capital firm focusing on innovations in food and agriculture. Acre's diverse portfolio includes notable investments in companies like Meati Foods, which specializes in clean, fungi-based protein meats and raised $50M in a Series B round co-led by Acre. Mori is another significant investment, providing silk-based coatings for food protection to reduce waste and extend shelf life. Inari, a unicorn company developing advanced seed breeding technology, is valued at $1.5B. Spoiler Alert is a B2B marketplace helping food businesses manage surplus food, thus reducing waste. Agrofy is an online platform for farm equipment and infrastructure products. Acre's investment strategy emphasizes sustainability and technological innovation in agrifood technology. Recently, Acre closed its third fund at $140 million, targeting advancements in agricultural robotics, AI, and machine learning. This includes investments in companies like Bonsai Robotics and Farm-ng, focusing on automation in agriculture. Leveraging extensive experience and strategic partnerships, including advisory roles from industry experts like Lynda Deakin from IDEO and Chef David Chang, Acre drives growth and innovation within its portfolio companies. The firm supports startups from pre-seed to Series B stages, ensuring they have the necessary resources and strategic guidance to succeed in the evolving agrifood tech sector.

Acrew Capital is a venture capital firm founded in 2019 and headquartered in Palo Alto, California. The firm focuses on investing in companies across various stages, from early to growth stages, emphasizing diversity and transformative technology. Acrew Capital operates two primary funds: the Long Term View (LTV) fund, which targets early-stage investments, and the Diversify Capital Fund (DCF), which focuses on growth-stage companies. The LTV fund invests in early-stage companies, typically in the Seed to Series A stages, with check sizes ranging from $1 to $15 million. The DCF fund is designed for growth-stage investments, offering $10 to $20 million per investment. Acrew Capital's investment strategy prioritizes deep domain expertise, diverse perspectives, and long-term commitments to their portfolio companies. The firm's core thesis areas include financial services, cybersecurity, data, augmented reality, virtual reality, web 3.0, and cryptocurrency sectors. Acrew Capital's notable investments include companies like Eden Health, BlockFi, and CipherTrace. They have successfully exited several investments through mergers and acquisitions, demonstrating a strong track record in identifying and nurturing high-potential startups​. The leadership team at Acrew Capital is composed of experienced professionals like Lauren Kolodny, Mark Kraynak, and Asad Khaliq, who bring extensive experience in venture capital and entrepreneurship. The firm's commitment to diversity is reflected in its team composition and investment approach, with a significant portion of its leadership being women or people of color​.

Act One Ventures, established in 2016 and based in Los Angeles, California, focuses on investing in early-stage companies, particularly in pre-seed and seed rounds. The firm primarily invests in sectors like e-commerce infrastructure, vertical SaaS, and fintech. Act One Ventures is known for its commitment to diversity, with over 70% of its portfolio companies led by women founders and those from underrepresented backgrounds. Notable investments by Act One Ventures include Cartwheel, a logistics and delivery software company; Dragonboat, a product portfolio management platform; Clovers, a human resources technology firm using conversational intelligence to enhance hiring practices; and Time Study, an AI-driven productivity tool for healthcare and enterprise applications. Act One Ventures takes a hands-on approach, working closely with founders to provide strategic guidance and support, helping startups navigate the challenges of early-stage growth. The firm's typical investment ranges from $500K to $3 million, reflecting its focus on providing substantial early support to its portfolio companies.

Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GlaxoSmithKline (GSK) in 2013. The firm focuses on advancing bioelectronic medicines and enabling technologies. APVC is headquartered in Cambridge, Massachusetts, with additional offices in Scotts Valley, California. APVC invests in companies that leverage advances in hardware, computing, and material science to regulate neural or cellular activity, aiming to treat a range of chronic diseases. Notable portfolio companies include Cala Health, which develops non-invasive neuromodulation therapies for conditions like essential tremor; CVRx, known for its FDA-approved BAROSTIM NEO therapy for heart failure; and Neuspera Medical, which is developing minimally invasive neuromodulation therapies for overactive bladder. The firm takes a hands-on role on the boards of startups, providing strategic guidance and support. APVC has made 25 investments to date, with recent notable investments in Exo, which offers AI-enabled handheld ultrasound imaging, and MicroTransponder, which focuses on therapies for neurological conditions. APVC's investment approach emphasizes diversity and inclusion within the healthcare and entrepreneurial communities. The leadership team includes Imran Eba and Juan-Pablo Mas, who bring extensive experience in venture capital and biotechnology investments.

Activate Capital is a San Francisco-based venture capital firm established in 2017 with a focus on investing in high-growth companies that are transforming industries through technology. The firm specializes in sectors such as climate tech, energy management, infrastructure technology, and IoT, aiming to foster a sustainable, resilient global economy. Activate Capital primarily targets Series B, C, and D funding rounds, providing capital to companies at a critical growth phase. The firm has built a diverse portfolio of innovative companies including Voltus, Element Analytics, StreetLight Data, and Optimal Dynamics, all of which leverage advanced technologies to solve environmental and economic challenges. Activate's focus areas span clean energy, smart cities, AI, and machine learning, aligning with its mission to support companies that are redefining how industries function while addressing climate change. With more than $1.5 billion in capital raised, Activate Capital is led by a team of seasoned investors, including Managing Partners Anup Jacob and David Lincoln, who have decades of experience in energy and infrastructure. Their investment approach emphasizes long-term partnerships, working closely with founders to build category-defining companies. Recent investments include Altana AI, a company focused on AI-driven logistics, and Sympower, which specializes in renewable energy and smart cities. Activate Capital’s commitment to sustainability-driven innovation positions it as a key player in the growing climate tech and infrastructure investment space, helping reshape the industrial landscape for a greener future.

Activate Venture Partners, formerly known as Milestone Venture Partners, is an early-stage venture capital firm founded in 1999 and based in New York City. The firm focuses on investing in high-growth technology companies, particularly those in the healthcare and enterprise software sectors. Their strategy emphasizes being the first institutional investor in startups, with over 85% of their portfolio companies receiving pre-revenue investments​. Notable investments in their portfolio include companies like Healthify, Diameter Health, and Cureatr, reflecting their strong focus on healthcare technology. Additionally, they have invested in technology firms like Canvs.ai and Cloudnexa, which provide services ranging from market research to AWS management. Activate Venture Partners typically leads seed and early-stage financing rounds with initial investments often below $5 million. They are known for their hands-on approach, offering strategic guidance and support to help startups scale effectively. The leadership team includes co-founders Edwin Goodman and Todd Pietri, along with partners like Glen Bressner and Don Yount. Their extensive experience and deep industry connections provide valuable insights and resources to the companies they invest in​.

Active Capital is a venture capital firm based in San Antonio, Texas, that focuses on leading seed-stage investments, primarily in B2B SaaS companies. Founded by Pat Matthews, Active Capital aims to support startups that are building cloud-based software and infrastructure with the potential to scale rapidly. The firm typically writes checks ranging from $500,000 to $2 million and prides itself on being highly involved with its portfolio companies, offering hands-on support to help them grow from seed to later stages. Active Capital is particularly active in markets outside of Silicon Valley, seeking to back talented entrepreneurs across the U.S. who are often overlooked by more geographically concentrated funds. Their portfolio includes notable companies like CallRail, LawnStarter, and Bestow, all of which are examples of scalable B2B solutions that align with their investment thesis​. The firm is committed to leading rounds, often taking a lead role in both investments and operational guidance. Active Capital prefers to work closely with founders who are building high-growth SaaS platforms, leveraging its extensive network of industry experts and fellow investors. With a focus on long-term partnerships, Active Capital is positioned as a strategic ally for early-stage companies that are ready to accelerate their market entry and growth.

Acumen is a pioneering impact investment firm dedicated to addressing poverty through a unique approach it calls “patient capital,” designed to fund social enterprises that serve the most marginalized populations. Since its inception in 2001 by Jacqueline Novogratz, Acumen has invested over $150 million across 150+ companies worldwide. Its portfolio spans essential sectors like clean energy, agriculture, healthcare, and education, all aimed at empowering low-income communities with sustainable solutions that can operate at scale. Acumen’s methodology combines financial investment with a strong emphasis on management and leadership support. By focusing on long-term growth rather than immediate returns, Acumen supports businesses in emerging markets like East and West Africa, India, Latin America, and the U.S., ensuring they grow in both impact and profitability. Some of their prominent initiatives, such as off-grid energy projects in sub-Saharan Africa and affordable healthcare solutions in South Asia, reflect their commitment to transforming critical services for underserved populations. In addition to financial investment, Acumen fosters a culture of moral leadership through Acumen Academy, which educates entrepreneurs and social innovators on creating impactful and inclusive businesses. This dual approach of investment and training allows Acumen to build a pipeline of leaders and companies equipped to drive systemic change. With an extensive global network and partners ranging from corporate foundations to local entrepreneurs, Acumen continually expands its reach, working tirelessly to reimagine the role of capital in tackling poverty.

Adapt Ventures is an early-stage venture capital firm with a global focus, investing in founders who have bold visions in sectors like fintech, software, healthcare, and consumer products. The firm typically writes checks ranging from $100,000 to $500,000 at the pre-seed and seed stages, intentionally not leading rounds or taking board seats to give founders autonomy. Their portfolio includes companies like Sanas, Clara, and Wander, showcasing their commitment to transformative, high-impact startups. Founded by brothers Ammar and Mohammed Amdani, Adapt takes a collaborative approach, ensuring hands-on support for their portfolio companies through each growth phase. The firm is well-known for leveraging its extensive network to assist startups with business development, fundraising, and scaling into new markets. This founder-first philosophy, coupled with a high degree of engagement, sets them apart in the VC space. Adapt Ventures has offices in Miami, New York, and Dubai, reflecting their broad geographic reach. The team, which includes partners like Ezra Kebrab and Alan Chang, brings deep expertise in areas like fintech, proptech, and consumer brands, providing founders with the resources and insights needed to scale their companies rapidly. With a goal of investing in around 10 to 12 new companies each year, Adapt offers focused, high-value support to its portfolio, making them a go-to partner for early-stage entrepreneurs.

Addition is a venture capital firm founded in 2019 by Lee Fixel, previously a key investor at Tiger Global. Based in New York, Addition focuses on early and growth-stage technology companies, emphasizing sectors like e-commerce, SaaS, and fintech. Their notable investments include high-profile companies such as Allbirds, Freshworks, Chainalysis, Delhivery, dLocal, Hugging Face, Snyk, and Warby Parker. Geographically, Addition primarily targets investments in the United States, though they have a broad international scope due to their interest in global tech innovators. Their investment strategy involves a significant allocation towards both early-stage and growth-stage companies, with about one-third of their capital dedicated to early-stage ventures and the rest to more mature businesses. This allows them to support startups through various phases of their development. Addition's team is led by Fixel, who is the sole partner and decision-maker, ensuring a streamlined and decisive investment process. The firm is known for its strategic and empathetic approach, focusing on building long-term partnerships with entrepreneurs and fostering growth in their portfolio companies through active engagement and support. For startups seeking investment, Addition values clear demonstrations of potential for market leadership and significant growth. They prefer companies with a proven track record of profitability and sustainable competitive advantages. The firm's commitment to preserving legacy and company culture makes them a preferred partner for founders looking for a strategic, long-term investor.

Adjacent is an early-stage venture capital firm led by Nico Wittenborn, a seasoned investor with prior experience at Point Nine Capital and Insight Partners. The fund stands out for its investments in high-growth, tech-driven companies such as Revolut, Chainalysis, Oura, and PhotoRoom. With a clear focus on the intersection of consumer technology and SaaS, Adjacent targets startups building platform-shifting innovations. Geographically, Adjacent leans towards U.S. and European markets, especially major hubs like New York and Paris. Their strategy is centered on relatively small, early-stage investments, often writing checks around $2-5M. Though the fund typically doesn't lead rounds, it plays a crucial role as a follow-on investor, backing companies that demonstrate early signs of scaling potential. Wittenborn's philosophy is rooted in not chasing $10B outcomes but rather in building a highly concentrated, collaborative portfolio. The fund invests across sectors like fintech, AI, and mobile applications, with recent deals including RevenueCat, Copilot, and Ostrom. Founders seeking to engage Adjacent are best suited to focus on scalability and clear market traction, as Wittenborn prefers lean operations with strong growth signals. The team operates from New York and actively reduces the number of companies they engage with to maintain close founder relationships.

Advancit Capital is a venture capital firm founded in 2011, focusing on early-stage investments in media, technology, and web3 startups. Co-founded by Shari Redstone and Jason Ostheimer, the firm leverages its deep industry relationships and strategic support to help accelerate the growth of its portfolio companies. Advancit Capital's notable investments include The Athletic, an online sports media company; Headspace, a provider of guided meditation and mindfulness training; and Thrive Global, a platform for mental well-being coaching. They also have investments in Public, a multi-asset investment platform, and Mux, a video performance monitoring platform. The firm has a portfolio of over 100 companies and has seen several successful exits, including the acquisitions of Wondery, a podcast streaming platform, and Mic, a media company targeting millennials. With a strong emphasis on forming long-term partnerships, Advancit Capital continues to support innovative startups addressing large opportunities ripe for disruption.

Advantage Capital is a prominent impact investment firm founded in 1992, dedicated to providing financing to businesses and communities often overlooked by traditional capital sources. The firm has invested over $4.2 billion in more than 800 companies across various industries, including technology, renewable energy, and affordable housing. Some of their notable investments include NevadaNanotech Systems, which develops portable devices for real-time chemical analysis, and North End Teleservices, a contact center services provider in North Omaha aimed at creating local jobs and economic growth. TurboSquid, a global online marketplace for digital 3D models, is another key investment that highlights Advantage Capital's support for tech innovation and economic development in New Orleans​​. Advantage Capital emphasizes impact investing, focusing on outcomes such as job creation, community revitalization, and environmental sustainability. In 2022, the firm invested $85 million in affordable housing and raised over $635 million for solar energy projects, underscoring their commitment to driving meaningful change in underserved areas.

Advent Life Sciences is a leading transatlantic venture capital firm that focuses on investing in early and mid-stage life sciences companies. The firm emphasizes innovation in areas such as new drug discovery, medical technology, enabling technologies, and vaccines. Advent Life Sciences takes a hands-on approach, working closely with management teams to bring their visions to life, aiming for superior financial returns by bringing innovative solutions to patients. Advent Life Sciences has a strong portfolio of companies that have brought significant advancements in healthcare. Notable investments include AviadoBio, which focuses on gene therapy for neurodegenerative disorders, and Amphista Therapeutics, which develops protein degradation technologies for targeted cancer therapies. The firm also backs companies like Cellnovo, which created a micro insulin pump with connectivity, and Centessa Pharmaceuticals, a novel asset-centric pharmaceutical company. The firm is known for its experienced team of professionals, combining deep technical, commercial, and financial expertise. Key team members include Don Drakeman, Majid Kazmi, and Katrine Bosley, who bring substantial industry knowledge and strategic guidance to their portfolio companies. Advent Life Sciences is committed to supporting the growth of life sciences innovations, helping companies navigate the complex journey from scientific discovery to market-ready products.

AENU is a venture capital fund that’s making waves by focusing on early-stage climate tech companies, aligning profitability with environmental and social impact. Based in Europe, AENU primarily invests in startups that tackle the climate crisis through innovations in energy transition, carbon economy, and sustainability. Their portfolio includes impactful companies such as Alcemy, Monta, Ocell, Trawa, and Hometree, which work on solutions ranging from low-carbon cement to intelligent energy management. With a geographic focus on Europe, especially the DACH region, Nordics, and the UK, AENU targets Seed and Series A investments, typically writing checks between €1-4 million. They often co-lead or lead rounds and always aim for board representation to ensure a strategic partnership. Their innovative Impact-as-a-Service (IaaS) offering helps portfolio companies scale while maintaining strong environmental, social, and governance (ESG) standards. Founded by Fabian Heilemann and Ferry Heilemann, AENU boasts a team of seasoned entrepreneurs and investors with a proven track record of scaling ventures. The fund is committed to systemic transformation within venture capital, pushing for stakeholder alignment and equitable growth. Startups looking to partner with AENU should expect a research-driven, high-impact approach, where both financial returns and climate outcomes are equally prioritized​.

Aera VC is a venture capital firm focused on investing in climate tech and frontier technologies that aim to advance humanity and create a sustainable future. Founded in 2016 by Derek Handley and Nick Winstone, Aera VC operates from New York, Singapore, and New Zealand. The firm invests globally, targeting early-stage companies that drive transformational change across various industries. Notable investments include Solugen, which transforms chemicals using plant-based processes, and Twelve, a company that recycles CO₂ into cost-competitive chemicals and fuels. Other significant investments are Shiok Meats, a Singapore-based company developing cell-based seafood, and Carbon Chain, which offers solutions to reduce greenhouse gas emissions in supply chains. Aera VC also supports startups like AstroForge, focused on space technology, and Paloma Health, an online medical practice specializing in hypothyroidism. Aera VC recently raised $42 million in the first close of its new climate-focused fund, which will be used to back up to 30 new seed investments over the next two years. The firm aims to support breakthrough technologies that can significantly reduce the world's carbon footprint and advance sustainable practices across various sectors.

AeroX Ventures is an early-stage venture capital firm focusing on cutting-edge technologies in Aerospace and Defense (A&D). Based in Winston-Salem, North Carolina, they target high-potential startups in areas such as advanced air mobility (AAM), autonomous systems, and smart manufacturing. Their investments span dual-use technologies, serving both military and commercial applications. Notable portfolio companies include Whisper Aero, Privateer, and Cyvl.ai. The firm typically invests between $0.5M and $3M, often co-investing alongside other VC firms but also leading rounds in some cases. With a keen interest in scaling companies that address complex challenges within the A&D ecosystem, AeroX leverages its industry knowledge and strategic advisory board to drive innovation and achieve rapid growth. The investment team is led by industry veterans like Kyle Mounts (CIO) and Aaron Ishikawa, both with deep expertise in A&D technologies. They are highly selective and prioritize businesses that demonstrate clear technological differentiation and strong market demand. Their strategy is not just financial; they actively mentor their portfolio companies, guiding them through regulatory landscapes and helping them position for exits via M&A or IPO. Startups looking to approach AeroX should have a well-defined product-market fit and be ready to scale in a competitive environment driven by technological innovation and defense needs.

AF Ventures, formerly known as AccelFoods, is a venture capital firm based in New York that invests in high-growth consumer product companies. Established in 2014, the firm focuses on sectors such as food and beverage, health and wellness, personal and household care, beauty, and pet products. AF Ventures typically invests in companies with $10-30M+ in top-line revenue, aiming to support the creation of enduring brands. Notable investments by AF Ventures include Harmless Harvest, ByHeart, Proud Source Water, Koia, Siete Foods, and Hello Bello. The firm provides financial capital along with strategic support, leveraging a network of industry experts to help portfolio companies achieve significant growth and innovation. AF Ventures is committed to driving consumer brand innovation on retail shelves and online platforms. They manage over 35 portfolio brands and continue to identify and support companies that offer unique and disruptive products in their respective markets.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

AgFunder is a venture capital firm founded in 2013, with headquarters in Silicon Valley. The firm focuses on investing in transformative technologies within the food and agriculture sectors. Their investment strategy emphasizes bold and impactful innovations that address critical challenges such as climate change, population growth, and sustainability in food production. Notable investments in AgFunder's portfolio include companies like DeHaat, which is a farmers' business network for smallholder farmers, and MycoWorks, known for producing leather alternatives from mycelium. Other significant investments include Verdant Robotics, a robotics-as-a-service company specializing in agricultural spraying, and Wefarm, a peer-to-peer network for farmers in Eastern Africa. AgFunder's thematic investment approach targets high-impact areas such as indoor farming, precision agriculture, and alternative proteins. They leverage their extensive network of founders, operators, and investors to support their portfolio companies in scaling globally. The firm has raised multiple funds and invested in over 85 companies, making them one of the most active foodtech and agtech VCs worldwide. Their leadership team combines technological expertise with market knowledge, enabling them to support startups effectively from early stages through to larger growth phases. AgFunder’s mission is to drive radical transformation in the food and agriculture systems through advanced technologies​.

Aglaé Ventures is a global technology-focused investment firm established in 2017, with headquarters in Paris and offices in New York and San Francisco. The firm is backed by Agache (formerly Groupe Arnault), the principal investment vehicle of Bernard Arnault, the controlling shareholder of LVMH. Aglaé Ventures invests in fast-growing tech companies at all stages, from seed to pre-IPO rounds, with investment sizes ranging from €100K to €100MM. Notable investments by Aglaé Ventures include high-profile companies such as Airbnb, Slack, Spotify, and Lyft. The firm is sector-agnostic but concentrates on asset-light and scalable business models, particularly in marketplaces, SaaS, content platforms, consumer apps, and digitally native vertical brands. Aglaé Ventures emphasizes a long-term investment approach, providing flexible and enduring capital while supporting portfolio companies with expertise in growth management, brand building, digital marketing, and global expansion strategies. The firm also leverages its extensive network, including access to the LVMH ecosystem, to accelerate the growth of its portfolio companies. The team at Aglaé Ventures includes experienced investors and entrepreneurs like Miyuki Matsumoto, Managing Partner and Head of US Investments, and co-founders Cyril Guenoun and Antoine Loison. The firm prides itself on its simple investment terms and quick decision-making processes, making it an attractive partner for ambitious founders​.

Aglaia Oncology Funds is a Dutch venture capital firm specializing in early-stage investments in oncology. Founded in 2004, the firm focuses on groundbreaking technologies that have the potential to transform cancer diagnosis and treatment. Aglaia actively collaborates with scientists and management teams to translate high-potential research into commercially and clinically successful products. Aglaia's portfolio includes notable companies such as Cristal Therapeutics, Inthera Bioscience, Macrophage Pharma, Mimetas, Modra Pharmaceuticals, and Sapreme Technologies. The firm has also seen successful exits with companies like Merus and Synthon. The team at Aglaia is led by partners Eric van der Putten, Karl Rothweiler, Mark Krul, and supported by a strong advisory board comprising experts in oncology and biotech, including Alan Barge, Sjoerd van der Burg, and Kees Melief. This team brings deep expertise in cancer research and drug development, ensuring that their portfolio companies receive comprehensive strategic support. Aglaia Oncology Funds emphasizes impact investing, aiming to generate both financial and social returns by advancing innovative cancer treatments.

Ahoy Capital is a boutique venture capital firm founded in 2018 by Chris Douvos. The firm specializes in early-stage investments, particularly in venture capital funds and startup companies. Ahoy Capital is based in Palo Alto, California, and is known for its concentrated investment strategy, focusing on high-potential, disruptive technologies and frontier ideas that are set to shape the future. Ahoy Capital's investment approach is distinct, leveraging the deep experience of its team, which has been instrumental in pioneering the micro-VC movement. The firm emphasizes maintaining a right-sized fund to avoid over-diversification, aiming to maximize returns by backing both established and emerging venture capital managers. This approach is driven by a strong belief that small, well-targeted investments are more effective in capturing outsized returns in the fast-evolving innovation ecosystem. The team at Ahoy Capital, led by Managing Directors Chris Douvos and Cliff Gilman, is highly engaged with both their investors and portfolio companies. They are recognized for their hands-on support and strategic guidance, helping their partners navigate the complexities of the startup landscape. Ahoy Capital also prioritizes close interaction with its investors, offering them deep insights and access to exclusive investment opportunities that are often not available elsewhere. Ahoy Capital’s strategy and operations reflect its commitment to being a thoughtful, engaged partner in the venture capital space, driving innovation and delivering strong, risk-adjusted returns to its investors.

Ahren Innovation Capital is a deep tech and science-focused investment firm, aiming to support transformational companies at the intersection of cutting-edge science and technology. With over $400 million in their latest fund, Ahren targets companies working in domains such as AI, genetics, robotics, and sustainable energy. They take an active role in nurturing early-stage to pre-IPO companies, focusing on ventures that have the potential to create new markets or disrupt existing ones. Ahren’s portfolio includes pioneering companies like Graphcore (AI hardware), Edifice Health (inflammatory disease diagnostics), and Meatable (cultivated meat). Their science partners include Nobel laureates and renowned scientists like Sir Gregory Winter and Lord Martin Rees, who bring deep expertise to the diligence process and ongoing business support. The firm has a strong network of strategic LPs, giving their portfolio access to key industry partners and customers. Led by Alice Newcombe-Ellis, Ahren's model blends visionary investment with commercial acumen, helping companies scale while maintaining a commitment to groundbreaking innovation. They prioritize building lasting relationships with founders, positioning themselves as trusted partners who contribute both capital and deep technical knowledge​.

AI Fund, founded by Andrew Ng, is a venture capital firm dedicated to investing in startups leveraging artificial intelligence to solve significant problems across various industries. The fund focuses on early-stage investments and aims to support AI-driven innovation that has the potential to transform industries and improve the quality of life. Notable investments by AI Fund include Workera, which provides personalized assessments and learning plans for upskilling in AI and data science; Landing AI, which specializes in computer vision solutions for manufacturing and industrial applications; and Cerebras Systems, known for its advanced AI compute solutions. Other significant investments include SambaNova Systems, a company focused on building advanced AI hardware and software platforms, and Osaro, which develops AI-driven robotic automation for industrial applications. AI Fund's strategy involves partnering with visionary founders to accelerate their growth and impact. They offer not only financial support but also access to a network of AI experts and industry leaders to help startups navigate challenges and scale their innovations effectively.

Audacious Ventures is a venture capital firm dedicated to supporting the world's most ambitious founders from the earliest stages of their entrepreneurial journeys. Founded in 2020, the firm has quickly made a name for itself with its unique approach that blends traditional seed-stage investing with a strong emphasis on talent acquisition for its portfolio companies. In April 2024, Audacious announced its $150 million second fund, Audacious 2.0, which continues its mission to invest in sectors such as AI, fintech, healthcare, construction tech, and climate tech. What sets Audacious apart is its deep focus on helping founders build A+ teams, particularly in critical areas like engineering, sales, and marketing. Half of Audacious' team comprises experienced recruiters who actively run searches for portfolio companies, ensuring they attract top-tier talent as they scale. This hands-on support reflects the firm’s belief that startup success hinges on exceptional teams and large market opportunities. Audacious Ventures has invested in several high-growth companies, including Vartana, Multiverse, Suppli, and Ignition. These investments underscore the firm’s commitment to backing startups that have the potential to become industry leaders. Unlike many venture firms, Audacious does not take board seats, preferring instead to focus on providing value through strategic hiring support and then stepping back to let founders lead their companies to success​.

Air Liquide, a global leader in gases, technologies, and services for industry and healthcare, is deeply committed to advancing sustainability and innovation through its strategic plan, ADVANCE. This strategy, designed for 2025, integrates financial performance with sustainable development goals, focusing heavily on decarbonization and the growth of key future markets, such as hydrogen and electronics. The company plans to reduce its CO₂ emissions by one-third by 2035 and aims for carbon neutrality by 2050. To achieve these goals, Air Liquide is investing significantly, with approximately 50% of its industrial investments allocated to the energy transition, including hydrogen technologies. The company is also simplifying its organizational structure to enhance agility and performance, enabling quicker decision-making and better customer service. Air Liquide’s efforts in decarbonization are demonstrated by projects like the large-scale Cryocap™ CO₂ capture unit in Rotterdam and the development of a global hydrogen distribution network through partnerships like TEAL Mobility with TotalEnergies. With over 66,000 employees across 60 countries, Air Liquide continues to drive forward with its dual focus on growth and sustainability, positioning itself as a leader in the transition to a low-carbon economy​.

Air Street Capital is a leading venture capital firm focused on AI-first companies, headquartered in London. Founded by Nathan Benaich, the fund aims to back innovative startups leveraging artificial intelligence across various sectors, including life sciences, enterprise software, and consumer technology. The firm has made significant investments in notable companies such as Exscientia, a pharmaceutical company listed on NASDAQ; Graphcore, an AI semiconductors company acquired by SoftBank; and Intenseye, a workplace safety platform utilizing computer vision. Other prominent investments include Recursion, ZOE, and Stability AI. Air Street Capital's investment strategy involves early-stage funding, actively iterating on product and market strategies from day one. The fund's typical investment size ranges from seed to Series A rounds, ensuring substantial support for startups at their most critical stages of development. The firm emphasizes creating enduring companies with lasting market impact, guided by a rigorous, science-driven approach to investment. The team at Air Street Capital includes experts like Alex Chalmers and Paula Pastor, who bring extensive experience in legal, operations, and platform development. Their collective expertise and strategic insights help portfolio companies navigate complex challenges and scale effectively. With a robust portfolio and a clear focus on AI-driven innovation, Air Street Capital stands out as a pivotal player in the venture capital landscape, driving forward the capabilities and applications of artificial intelligence across industries​.

Airbus Ventures, established in 2016 and headquartered in Menlo Park, California, is the venture capital arm of Airbus Group. The firm focuses on early to growth-stage investments in innovative startups that aim to address significant global challenges through advanced technologies. Their investment sectors include autonomous mobility, electrification, low-carbon economy, advanced materials, manufacturing systems, next-generation computing, sensing, and security. The portfolio of Airbus Ventures includes a wide range of companies that leverage cutting-edge technology. Notable investments include IonQ, a developer of quantum computing solutions; Astra, a provider of space mission launch solutions; and Humatics, which develops control systems for collaborative robots. Other significant investments are in companies like AEye, specializing in AI and cloud-enabled LiDAR sensors, and Tekion, an AI-driven dealership management system for auto dealers. Airbus Ventures has successfully nurtured numerous startups, with several achieving significant milestones such as public listings or acquisitions. For example, IonQ went public and is a leading player in the quantum computing space, while Astrocast and ispace are other prominent companies in their portfolio that have made substantial progress in their respective fields. The firm is managed by a team of experienced professionals, including Thomas d'Halluin, Claas Kohl, Lewis Pinault, and Mathieu Costes, who bring extensive expertise in venture capital and technology innovation.

AiSprouts is a Silicon Valley-based venture capital firm, specializing in AI-driven startups that aim to enhance human potential. Founded in 2019 by Suman Talukdar, the firm operates out of Menlo Park, California, and is investing from its second fund. AiSprouts targets early-stage companies, primarily focusing on sectors such as AI, robotics, and business software. Notable investments in their portfolio include HaydenAI, BoostupAI, and Zero Systems, with successful exits like Apprente (acquired by McDonald’s) and 6D.ai (acquired by Niantic). They typically invest in 8-10 companies per year, aiming for a total of 30 investments over three years. Recent activity includes the $90M Series C raise by HaydenAI and an $11M Series A for Activeloop. AiSprouts offers deep operational support, leveraging Talukdar’s experience with five back-to-back exits and a network of prominent Silicon Valley technologists and investors. Their investment strategy emphasizes AI applications across various industries, aiming for sustainable growth and technological impact.

AIX Ventures is a specialized venture capital firm dedicated to investing in early-stage AI startups. Founded by renowned AI practitioners such as Richard Socher, Chris Manning, and Pieter Abbeel, AIX Ventures is deeply embedded in the AI community. The firm’s focus is on partnering with companies where AI is a core component of the product, spanning sectors like natural language processing, robotics, healthcare, and more. AIX Ventures manages its investments through funds, including its recent $202 million Fund II, which underscores its commitment to driving the future of work through AI. The firm typically invests between $1 million and $5 million at the Pre-Seed to Series A stages and is known for leading funding rounds while collaborating with other top investors and angels. The firm's portfolio includes groundbreaking AI companies such as Hugging Face, Weights & Biases, You.com, and Perplexity. These companies are at the forefront of AI innovation, pushing the boundaries of what is possible in their respective fields. AIX Ventures is not just an investor but also a partner in company-building, offering strategic guidance, technical expertise, and a strong network to help founders navigate the complex challenges of scaling AI technologies. The firm’s goal is to be deeply involved with its portfolio companies from the early stages through to their long-term success.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

Alante Capital is an early-stage venture capital firm focused on fostering innovation in the fashion, home, and outdoor industries by investing in climate tech, deep tech, AI, and enterprise software. Co-founded by Karla Mora and Leslie Harwell, Alante Capital aims to address climate change and build a circular economy through their investments. They primarily target companies that are modernizing and building resilience in consumer industries, with a particular emphasis on reducing carbon emissions and improving the sustainability of supply chains. Alante Capital’s portfolio includes investments in companies like Insempra, Mango Materials, and Novoloop, which are pioneering sustainable solutions across various sectors. Their investment strategy is comprehensive, with a focus on technologies that transform how products are designed, produced, and managed throughout their lifecycle. The firm typically invests in North America and Europe, with check sizes ranging from pre-seed to Series A. The team, based in Santa Barbara, CA, and New York, brings a wealth of experience in impact investing, sustainable finance, and economic development. Karla Mora's background includes working with early-stage companies in emerging markets, while Leslie Harwell has a strong foundation in sustainable finance and capital strategy.

AlbionVC, founded in 1996 and based in London, is a leading venture capital firm that focuses on early-stage investments in B2B software, healthcare, and deep tech companies primarily in the UK. The firm manages around £1 billion in venture funds and supports companies from seed to Series B stages. Notable investments in AlbionVC's portfolio include Quantexa, a data and analytics company specializing in contextual decision intelligence; Oviva, which provides app-guided programs for changing dietary and lifestyle habits; and Phrasee, a brand language optimization solution. The firm has also seen successful exits, such as Orchard Therapeutics, which focuses on gene therapies for life-threatening diseases, and Egress Software, a provider of data security solutions. AlbionVC is known for its hands-on approach, providing long-term capital and expertise to help visionary founders scale their businesses. The firm's investment strategy is characterized by its deep sector knowledge and a strong focus on innovation and growth.

Aleph VC, founded in 2013 and based in Tel Aviv, is a prominent venture capital firm focused on early-stage investments in Israeli entrepreneurs. With $850 million under management, Aleph specializes in sectors such as fintech, digital health, cybersecurity, AI, and machine learning. The firm aims to build impactful global brands by providing strategic guidance and access to global markets. Notable investments in Aleph's portfolio include Lemonade, a global insurance company powered by AI and behavioral economics; Melio, which offers digital payment tools for small businesses; and Nexar, a dashcam and edge-AI platform for improved driving. Aleph has also backed companies like Freightos, a digital freight marketplace, and Placer.ai, a leader in location analytics. Aleph's investment strategy typically involves seed and early-stage funding, with investment sizes ranging from $2 million to $12 million. The firm has a strong track record of successful exits, including the public offerings of companies like Lemonade and Monday.com, and acquisitions such as Raftt by Wiz. The team at Aleph is led by co-founders Michael Eisenberg and Eden Shochat, along with partners Yael Elad and Tomer Diari. They leverage their extensive network and expertise to help portfolio companies grow and succeed on a global scale. Aleph's focus on innovation and strong support for its portfolio companies has established it as a leading venture capital firm in Israel​.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Aligned Climate Capital is a venture capital firm based in New York, with a sharp focus on investments that drive the decarbonization of the global economy. Founded in 2019 by veterans of the U.S. Department of Energy’s Loan Programs Office, Aligned has quickly established itself as a leader in climate-related investments, managing over $1.8 billion in assets across three primary strategies: venture capital, distributed solar, and climate infrastructure. Aligned's investment strategy revolves around identifying and backing companies that contribute to significant environmental impact while delivering strong financial returns. Notable investments include UtilityAPI, Sealed, and SWTCH, which are involved in energy services, consumer services, and commercial services, respectively. The firm tends to focus on later-stage ventures and infrastructure projects within the United States and Canada. The team, led by CEO Peter Davidson and COO Brendan Bell, leverages their deep expertise in finance and renewable energy to guide their portfolio companies towards growth and impact. The firm is headquartered in New York and Los Angeles, with a small but highly specialized team dedicated to aligning the success of their investments with the broader goal of mitigating climate change.